BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$330.01 USD
-14.59 (-4.23%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $329.77 -0.24 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Bio-Rad Laboratories (BIO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$370.20 | $446.00 | $315.00 | 7.43% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Bio-Rad Laboratories comes to $370.20. The forecasts range from a low of $315.00 to a high of $446.00. The average price target represents an increase of 7.43% from the last closing price of $344.60.
Analyst Price Targets (5 )
Broker Rating
Bio-Rad Laboratories currently has an average brokerage recommendation (ABR) of 2.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 2.25 a month ago based on four recommendations.
Of the five recommendations deriving the current ABR, one is Strong Buy and one is Buy. Strong Buy and Buy each account for 20% of all recommendations. A month ago, Strong Buy made up 25%, while Buy represented 25%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.40 | 2.40 | 2.25 | 2.25 | 2.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/27/2024 | Wells Fargo Securities | Brandon Couillard | Not Available | Hold |
8/16/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
8/2/2024 | Not Identified | Not Identified | Hold | Hold |
6/3/2024 | Not Identified | Not Identified | Not Available | Hold |
5/8/2024 | UBS | Dan Leonard | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.40 |
ABR (Last week) | 2.40 |
# of Recs in ABR | 5 |
Average Target Price | $370.20 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 63 of 253 |
Current Quarter EPS Est: | 2.13 |
BIO FAQs
Bio-Rad Laboratories, Inc. (BIO) currently has an average brokerage recommendation (ABR) of 2.40 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Bio-Rad Laboratories, Inc. (BIO) is $370.20. The current on short-term price targets is based on 2 reports.
The forecasts for Bio-Rad Laboratories, Inc. (BIO) range from a low of $315 to a high of $446. The average price target represents a increase of $12.18 from the last closing price of $330.01.
The current UPSIDE for Bio-Rad Laboratories, Inc. (BIO) is 12.18%
Based on short-term price targets offered by five analysts, the average price target for Bio-Rad Laboratories comes to $370.20. The forecasts range from a low of $315.00 to a high of $446.00. The average price target represents an increase of 7.43% from the last closing price of $344.60.